CHASE WILLIAM J bought Intellia Therapeutics ($NTLA) shares on the open market once in the last year, totaling about 1 million dollars, with the latest purchase on August 20, 2025. This ranks him 514th among nearly 5,000 individual insiders by purchase value, below the average of 1.46 million dollars across 3.29 transactions per insider. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 213 | $97.44 | 36,803.0000 | 36,160,998,000 | 0.58% | 0.00% |
| Oct. 15, 2025 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 275 | $75.52 | 36,590.0000 | 36,160,998,000 | 0.76% | 0.00% |
| Aug. 20, 2025 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Not found | P | Common Stock | 100000 | $10.03 | 134,693.0000 | 103,517,460 | 288.24% | 0.10% |
| July 15, 2025 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 533 | $38.53 | 36,315.0000 | 36,047,799,000 | 1.49% | 0.00% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Not found | A | Common Stock | 8000 | $0.00 | 34,693.0000 | 103,517,460 | 29.97% | 0.01% |
| May 29, 2025 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 6082 | $41.10 | 35,782.0000 | 35,296,858,000 | 20.48% | 0.00% |
| April 15, 2025 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 784 | $25.94 | 29,700.0000 | 35,296,858,000 | 2.71% | 0.00% |
| Jan. 15, 2025 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 1182 | $17.58 | 28,916.0000 | 33,893,409,000 | 4.26% | 0.00% |
| Oct. 30, 2024 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 210 | $13.62 | 27,734.0000 | 33,203,744,000 | 0.76% | 0.00% |
| Oct. 15, 2024 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 1054 | $14.01 | 27,524.0000 | 33,203,744,000 | 3.98% | 0.00% |
| June 25, 2024 | GRAIL, Inc. | $GRAL | CHASE WILLIAM J | Director | A | Common Stock | 26470 | $0.00 | 26,470.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Not found | A | Common Stock | 7737 | $0.00 | 26,693.0000 | 0 | 40.82% | 0.00% |
| June 12, 2024 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Director | A | Stock Option (right to buy) | 2447 | $0.00 | 2,447.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Director | A | Common Stock | 1673 | $0.00 | 18,956.0000 | 0 | 9.68% | 0.00% |
| April 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Director | A | Common Stock | 10483 | $0.00 | 17,283.0000 | 0 | 154.16% | 0.00% |
| April 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | CHASE WILLIAM J | Director | A | Stock Option (Right to Buy) | 14931 | $0.00 | 14,931.0000 | 0 | 9999.99% | 0.00% |